Drug approvals

This undated product image provided by Genentech shows a box for Xofluza, a pill for shortening the duration and easing symptoms of the flu. U.S. health regulators have approved the first new type of flu drug in two decades. The approval on Wednesday, Oct. 24, 2018, of Roche’s Xofluza comes ahead of this winter’s flu season. (Genentech via AP)
October 24, 2018 - 2:09 pm
TRENTON, N.J. (AP) — U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can reduce severity and shorten duration of flu symptoms...
Read More
October 19, 2018 - 8:12 am
LONDON (AP) — Europe's medicines regulator has recommended the approval of the first vaccine for dengue despite concerns about the vaccine's wide use and a lawsuit in the Philippines alleging it was linked to three deaths. The European Medicines Agency said Friday it had adopted a "positive opinion...
Read More
FILE - This Sept. 13, 2016, file photo, shows a selection of Johnson & Johnson brand first aid products arranged for a photo in Surfside, Fla. Johnson & Johnson reports earnings Tuesday, Oct. 16, 2018. (AP Photo/Wilfredo Lee, File)
October 16, 2018 - 8:07 am
A jump in prescription drug sales and a sharply reduced tax bill boosted Johnson & Johnson's third-quarter sales and profit, which beat Wall Street expectations. The world's biggest maker of health care products on Tuesday also slightly raised its profit forecast for the year. The New Brunswick...
Read More
October 02, 2018 - 6:55 pm
TRENTON, N.J. (AP) — U.S. regulators have approved a modernized version of a decades-old antibiotic used to treat a number of infections. Paratek Pharmaceuticals' Nuzyra (noo-ZAHY'-ruh) was designed to overcome the problem of resistance to tetracycline, an antibiotic widely used until recent years...
Read More

Pages